Ma J - Search Results

1

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.

Zhuang W, Ma J, Chen X, Wang G, Lu J, Chen Y, Dong H, Cai S, Zhang Y, Zhao X, Zhu Y, Xu C, Huang Y, Huang Z, Zhu X, Jiang H, Wang Z. Zhuang W, et al. Among authors: ma j. J Cancer. 2018 Jun 6;9(13):2302-2307. doi: 10.7150/jca.24932. eCollection 2018. J Cancer. 2018. PMID: 30026825 Free PMC article.

2

Risk factors for pneumonitis in patients treated with anti-programmed death-1 therapy: A case-control study.

Cui P, Liu Z, Wang G, Ma J, Qian Y, Zhang F, Han C, Long Y, Li Y, Zheng X, Sun D, Zhang J, Cai S, Jiao S, Hu Y. Cui P, et al. Among authors: ma j. Cancer Med. 2018 Aug;7(8):4115-4120. doi: 10.1002/cam4.1579. Epub 2018 May 23. Cancer Med. 2018. PMID: 29797416 Free PMC article.

3

Comprehensive analysis of age-related somatic mutation profiles in Chinese young lung adenocarcinoma patients.

Yang B, Li J, Li F, Zhou H, Shi W, Shi H, Sun S, Sun W, Wang J, Ma J, Yan X, Hu Y, Jiao S. Yang B, et al. Among authors: ma j. Cancer Med. 2019 Apr;8(4):1350-1358. doi: 10.1002/cam4.1839. Epub 2019 Mar 1. Cancer Med. 2019. PMID: 30821106 Free PMC article.

4

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.

Sun D, Ma J, Wang J, Han C, Qian Y, Chen G, Li X, Zhang J, Cui P, Du W, Wu Z, Chen S, Zheng X, Yue Z, Song J, Gao C, Zhao X, Cai S, Hu Y. Sun D, et al. Among authors: ma j. Cancer Immunol Immunother. 2019 Sep;68(9):1527-1535. doi: 10.1007/s00262-019-02386-w. Epub 2019 Sep 18. Cancer Immunol Immunother. 2019. PMID: 31535160 Free PMC article.

5

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients.

Ma J, Sun D, Wang J, Han C, Qian Y, Chen G, Li X, Zhang J, Cui P, Du W, Wu Z, Chen S, Zheng X, Yue Z, Song J, Gao C, Cai S, Hu Y. Ma J, et al. Cancer Immunol Immunother. 2020 Mar;69(3):365-372. doi: 10.1007/s00262-019-02452-3. Epub 2020 Jan 2. Cancer Immunol Immunother. 2020. PMID: 31897660 Free PMC article.

6

Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer.

Zhang F, Huang D, Li T, Zhang S, Wang J, Zhang Y, Wang G, Zhao Z, Ma J, Wang L, Sun D, Cui P, Cai S, Jiao S, Zhao L, Hu Y. Zhang F, et al. Among authors: ma j. J Cancer. 2020 Jan 1;11(3):741-749. doi: 10.7150/jca.37966. eCollection 2020. J Cancer. 2020. PMID: 31942197 Free PMC article.

7

Immunotherapy beyond progression in patients with advanced non-small cell lung cancer.

Ge X, Zhang Z, Zhang S, Yuan F, Zhang F, Yan X, Han X, Ma J, Wang L, Tao H, Li X, Zhi X, Huang Z, Hofman P, Prelaj A, Banna GL, Mutti L, Hu Y, Wang J. Ge X, et al. Among authors: ma j. Transl Lung Cancer Res. 2020 Dec;9(6):2391-2400. doi: 10.21037/tlcr-20-1252. Transl Lung Cancer Res. 2020. PMID: 33489801 Free PMC article.

8

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort.

Sun D, Ma J, Wang J, Zhang F, Wang L, Zhang S, Chen G, Li X, Du W, Cui P, Hu Y. Sun D, et al. Among authors: ma j. Ther Clin Risk Manag. 2018 Sep 11;14:1691-1700. doi: 10.2147/TCRM.S173041. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 30254451 Free PMC article.

9

[Construction and identification of mouse model with conditional knockout of p75 neurotrophin receptor gene in epidermal cells by Cre-loxP system].

Sun R, Cao YQ, Ma JX, Yin SY, Zhang M, Song R, Jiang H, Gao Y, Zhang HY, Feng Z, Liu J, Liu ZX, Wang YB. Sun R, et al. Among authors: ma jx. Zhonghua Shao Shang Za Zhi. 2019 Oct 20;35(10):740-745. doi: 10.3760/cma.j.issn.1009-2587.2019.10.007. Zhonghua Shao Shang Za Zhi. 2019. PMID: 31658545 Chinese.

10

Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer.

Huang D, Zhang F, Tao H, Zhang S, Ma J, Wang J, Liu Z, Cui P, Chen S, Huang Z, Wu Z, Zhao L, Hu Y. Huang D, et al. Among authors: ma j. Target Oncol. 2020 Feb;15(1):93-100. doi: 10.1007/s11523-020-00703-3. Target Oncol. 2020. PMID: 32052340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,975 results

Search Page

Filters